 |
JOURNAL TOOLS |
| Publishing options |
| eTOC |
| To subscribe |
| Submit an article |
| Recommend to your librarian |
ARTICLE TOOLS |
| Publication history |
| Reprints |
| Permissions |
| Cite this article as |
| Share |
YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
SPECIAL ARTICLE
Italian Journal of Vascular and Endovascular Surgery 2017 March;24(1):19-25
DOI: 10.23736/S1824-4777.17.01272-4
Copyright © 2017 EDIZIONI MINERVA MEDICA
language: English
Current management of aorto-iliac aneurysms
Pascal DESGRANGES 1, Hicham KOBEITER 2, Frederic COCHENNEC 1, Joseph TOUMA 1, Marek MAJEWSKI 1, Jean MARZELLE 1 ✉
1 Vascular Surgery Unit, Henri Mondor Hospital, Public Assistance Hospital of Paris, Paris, France; 2 Radiology Unit, Henri Mondor Hospital, Public Assistance Hospital of Paris, Paris, France
The vast majority of AAA is now treated by endovascular therapy (EVAR), as the current generation of devices has reduced device-related complications, with fair long-term results as long as surgeons comply with IFU, i.e. in favorable anatomies. Although there will always remain indications for open repair (OR), technological and technical advances such as fenestrated/branched endografts, parallel grafts and endovascular sealing of the aneurysm, will probably further reduce indications for OR. The major drawback of EVAR is the need for long-term surveillance in order to prevent the risk of late rupture.
KEY WORDS: Aortic aneurysm, abdominal - Surgical proceduresm operative - Aneurysm, ruptured - Complications